Rijnstate, Department of Surgery, Arnhem, the Netherlands; Radboud University Medical Center, Department of Surgery, Nijmegen, the Netherlands.
PALGA Foundation, Houten, the Netherlands.
Eur J Surg Oncol. 2024 Oct;50(10):108598. doi: 10.1016/j.ejso.2024.108598. Epub 2024 Aug 14.
The clinical value of different modes of CRM involvement in rectal cancer patients is unclear. This study aims to determine the clinical impact of different modes of circumferential resection margin (CRM) involvement in patients with a locally advanced rectal carcinoma.
A cohort of patients who were diagnosed with stage III rectal cancer between June 2014 and June 2020 was selected from the prospective Dutch nationwide pathology databank (PALGA). Histopathological and clinical data were analyzed according to the nature of CRM involvement (via primary tumor invasion, lymph node metastasis, tumor deposit, multiple factors) and analyses on recurrence and overall survival (OS) were performed.
3020 patients were included, of whom 12.4 % had a positive CRM. The majority of these patients (63.2 %) had CRM involvement by primary tumor invasion and in 9 % of patients multiple factors caused the positive CRM. The rates of local recurrence and distant metastasis were related to the nature of the CRM involvement, with lowest rate for lymph node metastasis and highest rate for multiple factors. On multivariate analysis, CRM involvement by primary tumor invasion, tumor deposits and multiple factors, but not by lymph node metastasis, were associated with poor OS.
This nationwide population based study highlights the clinical importance of reporting the nature of CRM involvement in rectal cancer patients. Lymph node metastasis involving the CRM does not bear the same risks for local recurrence, distant metastases and OS as CRM involvement by primary tumor invasion or CRM involvement by multiple factors.
不同模式的环周切缘(CRM)累及在直肠癌患者中的临床价值尚不清楚。本研究旨在确定局部进展期直肠癌患者中不同模式的CRM 累及对临床的影响。
从前瞻性荷兰全国病理数据库(PALGA)中选择了 2014 年 6 月至 2020 年 6 月期间诊断为 III 期直肠癌的患者队列。根据 CRM 累及的性质(通过原发肿瘤侵犯、淋巴结转移、肿瘤沉积、多种因素)分析组织病理学和临床数据,并进行复发和总生存(OS)分析。
共纳入 3020 例患者,其中 12.4%的患者 CRM 阳性。这些患者中的大多数(63.2%)是由于原发肿瘤侵犯导致 CRM 累及,9%的患者是多种因素导致 CRM 阳性。局部复发和远处转移的发生率与 CRM 累及的性质有关,淋巴结转移的发生率最低,多种因素的发生率最高。多因素分析显示,原发肿瘤侵犯、肿瘤沉积和多种因素导致的 CRM 累及与较差的 OS 相关,而淋巴结转移导致的 CRM 累及与 OS 无关。
这项全国范围内的基于人群的研究强调了报告直肠癌患者 CRM 累及性质的临床重要性。CRM 累及淋巴结转移与局部复发、远处转移和 OS 风险并不像原发肿瘤侵犯或多种因素导致的 CRM 累及那样高。